Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Epidemiological Observational Study for Retrospective and Prospective Evaluation of for the Prevalence of Cerebrotendinous Xanthomatosis (CTX) Disease in Neurology and Pediatric Metabolism Clinics in Turkey

NCT04113083 is registered in ClinicalTrials.gov with TRPHARM as lead sponsor.

NCT NCT04113083
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04113083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Epidemiological Observational Study for Retrospective and Prospective Evaluation of for the Prevalence of Cerebrotendinous Xanthomatosis (CTX) Disease in Neurology and Pediatric Metabolism Clinics in Turkey
Lead sponsor
TRPHARM
Phase
Observational
Overall status
Terminated
Start date
October 19, 2019
Completion date
June 10, 2022
Enrollment
22 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

ctx - cerebrotendinous xanthomatosis